Acquisition of APIRx

For personal use only APIRX Intellectual Property Families 19 granted and 23 pending patents to secure commercial exclusivity and our R&D investment. Some patents meet more than one of the categories below: Extraction 3 Granted 2 Pending Cannabinoid drug development pipeline Formulation/Extraction Chewing gum (also combo products) Ultra-high bioavailability chewing gum / chewable tablet Oral care Ophthalmic solutions Suppositories Extraction of THC, CBD, CBG Cannabinoid sugar alcohol Microencapsulation of cannabinoids Sustained release technology API modification 4 Pending Incannex Methods of use |||||| Treat glaucoma and conjunctivitis Treat atopic dermatitis Antimicrobial Treat Vitiligo Treat Osteonecrosis of the jaw Treat psoriasis Formulation 17 Granted 15 Pending Methods of use 3 Granted 5 Pending Cannabinoid delivery methods with increased bioavailability and altered release profiles which provide opportunity to develop unique cannabinoid products and or products with advantages over established cannabinoid medicines. Shareholder Presentation 9

View entire presentation